Because azacytidine tablets are not listed in China at present, patients can't buy it in domestic pharmacies or hospital pharmacies, let alone reimburse it with medical insurance.
Azacytidine is an anti-metabolic and anti-tumor drug, which is mainly used for adult high-risk myelohyperplasia and abnormal syndrome. It is also used to treat chronic myelomonocytic leukemia and acute myeloid leukemia.